Hello, everyone, and how are you today? We are doing just fine, thank you, despite the gloomy clouds lingering overhead. Our spirits remain as sunny as ever. In fact, this calls for celebration and so please join us as we reach for another cup of delicious stimulation. We are back to Southern Pecan for those keeping track. Meanwhile, there is much to do. So as usual, we have assembled some tidbits for your reading pleasure. We hope you have a meaningful and productive day and, of course, do reach out if you hear something fascinating. …

President Trump, faced with multiple crises and falling poll numbers less than five months before the presidential election, is prodding top health officials to move faster on a historically ambitious timeline to approve a Covid-19 vaccine by year’s end, The Washington Post writes. In a meeting last month, Trump pushed Health and Human Services Secretary Alex Azar repeatedly to speed the unprecedented timeline. Trump wants some people to be able to get a vaccine sooner than the end of the year to demonstrate an end to the pandemic is within reach.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy